From the University of Texas Southwestern Medical Center, Dallas, TX; Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo; Long Island Gynecologic Oncologists, Smithtown, NY; Dana-Farber Partners Cancer Care, Massachusetts General Hospital, Boston, MA; University of Oklahoma, Oklahoma City, OK; Abington Memorial Hospital, Rosenfeld Cancer Center, Abington, PA; University Hospital Case Medical Center, Cleveland, OH; and Virginia Commonwealth University, Richmond,...
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial”.
Mark F. Brady, Ursula A. Matulonis, Austin Miller, Elise C. Kohn, Elizabeth M. Swisher +16 more
John A. Blessing, Carolyn N. Krasner, Robert S. Mannel, Parviz Hanjani, Michael L. Pearl +5 more